questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Processus néoplasiques
Processus néoplasiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic du cancer
Biopsie
Dépistage du cancer
Mammographie
Biopsie
Analyse histologique
Marqueurs tumoraux
Cancer
Stadification du cancer
Imagerie médicale
Symptômes
5
Symptômes du cancer
Fatigue
Types de cancer
Symptômes
Prévention
5
Prévention du cancer
Mode de vie sain
Alimentation
Antioxydants
Exercice physique
Risque de cancer
Traitements
5
Chimiothérapie
Radiothérapie
Immunothérapie
Système immunitaire
Radiothérapie
Rayonnements
Chimiothérapie
Effets secondaires
Complications
5
Complications du cancer
Métastases
Métastases
Traitement du cancer
Douleur cancéreuse
Gestion de la douleur
Chimiothérapie
Complications
Effets secondaires
Soins de soutien
Facteurs de risque
5
Facteurs de risque
Tabagisme
Hérédité
Antécédents familiaux
Produits chimiques
Risque de cancer
Alimentation
Risque de cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Processus néoplasiques : Questions médicales les plus fréquentes",
"headline": "Processus néoplasiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Processus néoplasiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anaplasie",
"alternateName": "Anaplasia",
"url": "https://questionsmedicales.fr/mesh/D000708",
"about": {
"@type": "MedicalCondition",
"name": "Anaplasie",
"code": {
"@type": "MedicalCode",
"code": "D000708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carcinogenèse",
"alternateName": "Carcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D063646",
"about": {
"@type": "MedicalCondition",
"name": "Carcinogenèse",
"code": {
"@type": "MedicalCode",
"code": "D063646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transformation cellulaire néoplasique",
"alternateName": "Cell Transformation, Neoplastic",
"url": "https://questionsmedicales.fr/mesh/D002471",
"about": {
"@type": "MedicalCondition",
"name": "Transformation cellulaire néoplasique",
"code": {
"@type": "MedicalCode",
"code": "D002471",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cocancérogenèse",
"alternateName": "Cocarcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D003043",
"about": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse",
"code": {
"@type": "MedicalCode",
"code": "D003043",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Invasion tumorale",
"alternateName": "Neoplasm Invasiveness",
"url": "https://questionsmedicales.fr/mesh/D009361",
"about": {
"@type": "MedicalCondition",
"name": "Invasion tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Infiltration leucémique",
"alternateName": "Leukemic Infiltration",
"url": "https://questionsmedicales.fr/mesh/D017254",
"about": {
"@type": "MedicalCondition",
"name": "Infiltration leucémique",
"code": {
"@type": "MedicalCode",
"code": "D017254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"alternateName": "Neoplasm Metastasis",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Extension extranodale",
"alternateName": "Extranodal Extension",
"url": "https://questionsmedicales.fr/mesh/D000079822",
"about": {
"@type": "MedicalCondition",
"name": "Extension extranodale",
"code": {
"@type": "MedicalCode",
"code": "D000079822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastase lymphatique",
"alternateName": "Lymphatic Metastasis",
"url": "https://questionsmedicales.fr/mesh/D008207",
"about": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique",
"code": {
"@type": "MedicalCode",
"code": "D008207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Micrométastase tumorale",
"alternateName": "Neoplasm Micrometastasis",
"url": "https://questionsmedicales.fr/mesh/D061206",
"about": {
"@type": "MedicalCondition",
"name": "Micrométastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D061206",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.695"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Essaimage tumoral",
"alternateName": "Neoplasm Seeding",
"url": "https://questionsmedicales.fr/mesh/D009366",
"about": {
"@type": "MedicalCondition",
"name": "Essaimage tumoral",
"code": {
"@type": "MedicalCode",
"code": "D009366",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.830"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastases d'origine inconnue",
"alternateName": "Neoplasms, Unknown Primary",
"url": "https://questionsmedicales.fr/mesh/D009382",
"about": {
"@type": "MedicalCondition",
"name": "Métastases d'origine inconnue",
"code": {
"@type": "MedicalCode",
"code": "D009382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.895"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cellules tumorales circulantes",
"alternateName": "Neoplastic Cells, Circulating",
"url": "https://questionsmedicales.fr/mesh/D009360",
"about": {
"@type": "MedicalCondition",
"name": "Cellules tumorales circulantes",
"code": {
"@type": "MedicalCode",
"code": "D009360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récidive tumorale locale",
"alternateName": "Neoplasm Recurrence, Local",
"url": "https://questionsmedicales.fr/mesh/D009364",
"about": {
"@type": "MedicalCondition",
"name": "Récidive tumorale locale",
"code": {
"@type": "MedicalCode",
"code": "D009364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.655"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie résiduelle",
"alternateName": "Neoplasm, Residual",
"url": "https://questionsmedicales.fr/mesh/D018365",
"about": {
"@type": "MedicalCondition",
"name": "Maladie résiduelle",
"code": {
"@type": "MedicalCode",
"code": "D018365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance oncogène",
"alternateName": "Oncogene Addiction",
"url": "https://questionsmedicales.fr/mesh/D000074723",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance oncogène",
"code": {
"@type": "MedicalCode",
"code": "D000074723",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques",
"alternateName": "Neoplastic Processes",
"code": {
"@type": "MedicalCode",
"code": "D009385",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Barbara A Centeno",
"url": "https://questionsmedicales.fr/author/Barbara%20A%20Centeno",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org."
}
},
{
"@type": "Person",
"name": "Sarah C Thomas",
"url": "https://questionsmedicales.fr/author/Sarah%20C%20Thomas",
"affiliation": {
"@type": "Organization",
"name": "Office of Chief Medical Examiner, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Guoqiang Zeng",
"url": "https://questionsmedicales.fr/author/Guoqiang%20Zeng",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Honglan Zhou",
"url": "https://questionsmedicales.fr/author/Honglan%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Yuantao Wang",
"url": "https://questionsmedicales.fr/author/Yuantao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Placenta Accreta Spectrum.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005229"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiology and Pathophysiology of the Placenta.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39403751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2024.39.e271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Processus néoplasiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Processus néoplasiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Processus néoplasiques",
"description": "Comment diagnostiquer un cancer ?\nQuels tests sont utilisés pour le dépistage ?\nQu'est-ce qu'une biopsie ?\nQuels sont les marqueurs tumoraux ?\nComment évaluer le stade d'un cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Processus néoplasiques",
"description": "Quels sont les symptômes courants du cancer ?\nComment reconnaître une tumeur ?\nQuels signes indiquent un cancer avancé ?\nLes symptômes varient-ils selon le type de cancer ?\nQu'est-ce que la cachexie ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Processus néoplasiques",
"description": "Comment prévenir le cancer ?\nLe vaccin contre le HPV prévient-il le cancer ?\nQuels aliments aident à prévenir le cancer ?\nL'exercice physique réduit-il le risque de cancer ?\nLe dépistage précoce est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Processus néoplasiques",
"description": "Quels sont les traitements standards du cancer ?\nQu'est-ce que l'immunothérapie ?\nComment fonctionne la radiothérapie ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQuand est-ce que la chirurgie est nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Processus néoplasiques",
"description": "Quelles sont les complications du cancer ?\nComment les métastases affectent-elles le traitement ?\nQu'est-ce que la douleur cancéreuse ?\nLes traitements peuvent-ils causer des complications ?\nComment gérer les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Processus néoplasiques",
"description": "Quels sont les principaux facteurs de risque du cancer ?\nL'hérédité joue-t-elle un rôle dans le cancer ?\nLe stress est-il un facteur de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?\nL'alimentation influence-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Placenta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le dépistage ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent mammographies, coloscopies et tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une biopsie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie consiste à prélever un échantillon de tissu pour analyse histologique."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs tumoraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs tumoraux sont des substances produites par les cellules cancéreuses, détectables dans le sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer le stade d'un cancer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stade est évalué par des examens d'imagerie et des classifications comme TNM."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du cancer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, perte de poids, douleurs et changements cutanés."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une tumeur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une tumeur peut se manifester par une masse palpable, des douleurs ou des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un cancer avancé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs persistantes, des saignements inexpliqués et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de cancer présente des symptômes spécifiques selon l'organe touché."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la cachexie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cachexie est une perte de poids et de masse musculaire souvent associée au cancer."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, l'évitement du tabac et des dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le HPV prévient-il le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre le HPV réduit le risque de cancers liés au virus, comme le cancer du col."
}
},
{
"@type": "Question",
"name": "Quels aliments aident à prévenir le cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fruits, légumes, grains entiers et aliments riches en antioxydants sont bénéfiques."
}
},
{
"@type": "Question",
"name": "L'exercice physique réduit-il le risque de cancer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs types de cancer."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet de détecter le cancer à un stade plus traitable."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements standards du cancer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et immunothérapie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'immunothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunothérapie utilise le système immunitaire pour combattre les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la radiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie utilise des rayonnements pour détruire les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la chimiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections."
}
},
{
"@type": "Question",
"name": "Quand est-ce que la chirurgie est nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour retirer des tumeurs localisées ou pour un diagnostic."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent métastases, infections, et effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Comment les métastases affectent-elles le traitement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases compliquent le traitement et peuvent nécessiter des approches plus agressives."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la douleur cancéreuse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur cancéreuse est causée par la tumeur ou les traitements, nécessitant une gestion adéquate."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des complications comme des infections."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des médicaments, des soins de soutien et des conseils nutritionnels."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'alcool, l'obésité et l'exposition à des agents carcinogènes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans le cancer ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de certains types de cancer."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer le risque de cancer, bien que les preuves soient variées."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques comme l'amiante ou le benzène est un facteur de risque."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses et pauvre en fibres peut augmenter le risque de cancer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org.
Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA, Barbara.Centeno@moffitt.org.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Office of Chief Medical Examiner, New York, New York, USA.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Laborato´ rio de Embriologia Molecular e Caˆncer, Federal University of Santa Catarina, Floriano´ polis, SC 88040-900, Brazil.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Suhut State Hospital, 03800, Afyon, Turkey.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Hacettepe University School of Medicine, Sihhiye, 06230, Ankara, Turkey.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. j.nawabi@uke.de.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Anaesthesiology and Intensive Care, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1 St., 71-281 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, Banner-University Medical Center, College of Medicine, University of Arizona, Tucson AZ, USA.
Publications dans "Processus néoplasiques" :
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is partic...
We are pleased to present this Special Issue of the...
Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation...
A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal vali...
Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.7...
The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas....
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
The objective of this study was to assess the performance of ultrasound and magnetic resonance imaging (MRI) features in helping to classify the type of placenta accreta spectrum (PAS; accreta/increta...
We conducted a retrospective study in 82 pregnant women with PAS who underwent ultrasound and MRI examination of the pelvis before delivery (from an initial cohort of 185 women with PAS). We estimated...
Among the 82 patients, 29 (35%) had placenta accreta/increta and 53 (65%) had placenta percreta. The best features to discriminate between placenta accreta/increta and placenta percreta with ultrasoun...
The nomogram we developed to predict the risk of placenta percreta among patients with PAS had good discriminative capabilities. This performance and its impact on maternal morbidity should be confirm...
Prolactin, a pituitary hormone that was discovered about 80 years ago and is primarily known for its functions in mammary gland development and lactation, is now known to participate in numerous funct...
Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated t...
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....